Recruiting NCT05296889

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical

Trial Parameters

Condition Spine Fracture

Sponsor Aesculap AG

Study Type OBSERVATIONAL

Phase N/A

Enrollment 200

Sex ALL

Min Age 18 Years

Max Age N/A

Start Date 2021-07-21

Completion 2026-06

All Conditions

Spine Fracture Degenerative Disc Disease Spinal Instability Spinal Tumor Degenerative Myelopathy

Interventions

posterior stabilization for the cervical spine

Brief Summary

Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications

Eligibility Criteria

Inclusion Criteria: * Patient is minimum 18 years old * Informed Consent in the documentation of clinical and radiological results * Patient has indication according to Instructions for Use (IFU) * Patient is not pregnant Exclusion Criteria: * Patient's clear unability or unwillingness to participate in follow-up examinations

Related Trials

NCT05296889

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical

View Trial →

VIEW ON CLINICALTRIALS.GOV ↗ MORE SPINE FRACTURE TRIALS